Clear Labs, Inc.

The Florida Department of Health (DOH) Bureau of Public Health Laboratories (BPHL) is pursuing a single-source procurement for two Clear Dx Instrument Systems to support viral disease outbreak detection activities across laboratories in Miami, Tampa, and Jacksonville. The procurement includes comprehensive system components such as software, reagents, and maintenance services, with a critical objective of enabling rapid real-time genomic surveillance that allows public health officials to make timely and actionable decisions. The systems must provide testing capabilities within a 24-hour timeframe to minimize client distress and prevent viral spread, specifically supporting outbreak detection activities reported to the Centers for Disease Control and Prevention (CDC). This procurement is being conducted under Chapter 60A-1.045 of the Florida Administrative Code, with a posted date of December 6, 2024, and a response deadline of January 3, 2025. The DOH requires a platform that can perform rapid genomic sequencing and identification of nucleic acid sequences, with an emphasis on delivering results that support immediate public health interventions.

Clear Labs, Inc. has been identified as the sole source provider for this procurement, as they are the exclusive manufacturer and distributor of the Clear Dx Instrument system in the United States. The estimated contract value is $2,992,704.00, with a proposed contract term of three years. The procurement encompasses chemical evaluation instruments, electrical measuring equipment, clinical analyzer reagents, and laboratory maintenance services, categorized under specific UNSPSC codes including 41113000, 41113600, 41116000, and 81101706. While no specific set-aside designations or disadvantaged enterprise requirements are explicitly mentioned, the procurement is geographically focused on Florida's state laboratories. The unique justification for the single-source selection is the system's capability to provide an 18-hour turnaround time, which is deemed essential for rapid real-time results and timely treatment decisions throughout the state's public health infrastructure.